Lv1
40 积分 2023-06-10 加入
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis
5天前
已完结
The unique properties of IgG4 and its roles in health and disease
1个月前
已完结
Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis
5个月前
已完结
Advances in the Application of Designed Ankyrin Repeat Proteins (DARPins) as Research Tools and Protein Therapeutics
6个月前
已完结
Myasthenia Gravis and the Tops and Bottoms of AChRs
8个月前
已完结
Treating myasthenia gravis beyond the eye clinic
10个月前
已完结
Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome
11个月前
已关闭
M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
11个月前
已完结
Small molecule improves muscle function in myasthenia gravis
11个月前
已关闭
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis
11个月前
已完结
皖公网安备34019202002308
